Pharmaceutical Technology8 小时
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
PrintWeek13 小时
Indian label converters are stepping up by adding new machines: Ajay RaoRane
Label converters in India are stepping up by adding new machines, whether from European or local manufacturers. When we visit ...